AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.440
+0.050 (3.60%)
Jul 31, 2026, 3:59 PM HKT

AIM Vaccine Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-675.46-277.23-1,301-319.6-692.77
Depreciation & Amortization
151.71165.46169.18163.41142.24
Other Amortization
6.626.575.523.032.06
Loss (Gain) From Sale of Assets
0.460.147.150.690.21
Asset Writedown & Restructuring Costs
525.7732.751,785--
Loss (Gain) From Sale of Investments
-0.01-0.08--3.07-1.67
Stock-Based Compensation
---14.2225.76952.13
Provision & Write-off of Bad Debts
-7.01-6.264.1827.227.98
Other Operating Activities
51.7343.7-932.86-131.1510.67
Change in Accounts Receivable
-66.83-112.4343.35-16.16-201.77
Change in Inventory
6.520.45-15.64-161.99-136.36
Change in Accounts Payable
29.08-9.46-13.2321.8213.79
Change in Unearned Revenue
-17.71-21.65-0.2616.12-28.91
Change in Other Net Operating Assets
62.62257.2397.5663.625.82
Operating Cash Flow
67.4799.19-165.5-110.3293.4
Operating Cash Flow Growth
-31.97%----62.69%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-114.41-121.75-158.92-779.01-1,125
Sale of Property, Plant & Equipment
0.360.011.660.190.02
Cash Acquisitions
-----250.38
Sale (Purchase) of Intangibles
-124.36-115.76-80.14-77.33-0.23
Investment in Securities
87.0151.968.12-56.935.9
Other Investing Activities
43.6623.2-42.6954.9332.55
Investing Cash Flow
-107.73-162.35-271.96-858.15-1,338

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
1,2041,0891,4581,282537.83
Long-Term Debt Repaid
-1,326-1,054-1,048-452.86-261.04
Net Debt Issued (Repaid)
-122.7734.63410.27829.16276.79
Issuance of Common Stock
70.06--162.02553.48
Other Financing Activities
-58.94-60.85-48.2-10.8-42.24
Financing Cash Flow
-111.65-26.22362.07980.37788.02

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.220.52.27-2.38-
Net Cash Flow
-151.69-88.88-73.129.53-456.09

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-46.93-22.56-324.42-889.33-1,032
Free Cash Flow Growth
-----
Free Cash Flow Margin
-4.03%-1.75%-27.32%-70.35%-65.73%
Free Cash Flow Per Share
-0.04-0.02-0.27-0.74-0.89
Levered Free Cash Flow
-130.3214.41-1,217-801.43-514.34
Unlevered Free Cash Flow
-94.1752.4-1,189-785.37-507.65

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
58.0160.8543.224.5910.3
Cash Income Tax Paid
11.8417.980.9259.5790.03
Change in Working Capital
13.66134.14111.78-76.6-327.44